![]() |
|
|
Vol. 291, Issue 2, 717-724, November 1999
Institute of Surgical Sciences, Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden
| |
Abstract |
|---|
|
|
|---|
Relaxations of segments of rat distal colon were elicited by hypertonic solutions of potassium (K+; final concentration, 20.8 or 50.8 mM). The initial part of the response to K+ was antagonized by the nerve blocker tetrodotoxin. This effect could, moreover, be significantly antagonized by apamin (a blocker of K+ channels), reactive blue 2 (a P2y-purinoceptor antagonist), NG-nitro-L-arginine (an inhibitor of NO synthase), 1H-[1,2,4]- oxadiazolo[4,3-a]quinoxaline-1-one (ODQ; an inhibitor of soluble guanylyl cyclase), or N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89; an inhibitor of cAMP-dependent protein kinase). Sodium nitroprusside (a donor of NO) and vasoactive intestinal peptide (VIP) both relaxed the tissues. The response to sodium nitroprusside was abolished by ODQ and unaffected by H-89, and that to VIP was partially inhibited by VIP10-28 (a VIP receptor antagonist), ODQ, or H-89. When combining reactive blue 2 and NG-nitro-L-arginine, the response to 50.8 mM K+ was reduced by ~70% and was abolished by the concomitant administration of these antagonists and VIP10-28. ATP, NO, and VIP may, thus, be inhibitory neurotransmitters in rat distal colon.
| |
Introduction |
|---|
|
|
|---|
Chemical
activation of the nerve supply of a preparation of smooth muscle may be
more selective than electrical stimulation for the analysis of
neurotransmission mechanisms. Thus, different compounds may excite
different subpopulations of neurons, as investigated mainly in
afferent, but also to some extent efferent, nerves (Maggi, 1991
; Toda
et al., 1992
; Broadley, 1996
; Hong et al., 1996
; Okamura et al., 1998
).
With reference to the gut, K+ may be of
particular interest. Gabella (1978) noted that (isotonic) K+ solutions (concentrations, 36-127 mM), when
administered to isolated preparations of guinea pig gastrointestinal
tract, elicited triphasic responses (relaxation followed by contraction
and a secondary relaxation). The first component could be abolished by
the nerve-blocking agent tetrodotoxin (TTX) but was not affected by the
noradrenergic nerve blocker guanethidine. These findings suggest that
the TTX sensitive component be due to the activation of inhibitory,
nonadrenergic motoneurons to the muscle (Gabella, 1978).
Furthermore, Toda et al. (1992)
reported that selectively
nonadrenergic, neurogenic relaxations of the longitudinal muscle of
canine duodenum could be elicited by K+. Such
relaxations were abolished by interference with NO synthase (NOS) but
were unchanged by the inhibitor of
Na+,K+- ATPase, ouabain.
In a recent follow-up study on the longitudinal muscle of canine
proximal colon, these authors noted that K+
elicited neurogenic relaxations that could be reduced (but not abolished) by either ouabain or an NOS antagonist (Okamura et al.,
1998
).
In the current study, which was undertaken with a preparation of the
longitudinal muscle of rat distal colon, we investigated the effect of
the administration of K+ to the tissue with the
following, specific aims: Could neurogenic relaxations be elicited by
K+? If so, what similarities or differences are
there with regard to the action of K+ on other
tissues (cf. Toda et al., 1992
; Tøttrup et al., 1993
; Okamura et al.,
1998
) when investigated with a variety of nerve-blocking or
neurotransmitter-blocking agents? Moreover, which transmitter candidates could mediate this response, with a specific focus on ATP,
NO, and vasoactive intestinal peptide (VIP; for a review, see Bennett,
1997
)? Finally, are the second messengers cAMP and cGMP involved in
such an effect to K+?
| |
Materials and Methods |
|---|
|
|
|---|
General.
The study design was approved by the Ethics
Committee of the Göteborg University. Colon tissue was obtained
from male Sprague-Dawley rats (B & K Universal AB, Sollentuna, Sweden;
210-400 g body weight). The animals were sacrificed by exsanguination
during pentobarbital anesthesia (60 mg/kg i.p.). A segment of the
distal colon (40-mm length; anal end situated ~40 mm proximal to the
anal orifice) was removed and immediately placed in chilled oxygenated
(95% O2/5% CO2) Krebs' solution containing
115.5 mM NaCl, 4.6 mM KCl, 1.2 mM KH2PO4, 21.9 mM NaHCO3, 1.2 mM MgSO4, 11.5 mM glucose, and
2.5 mM CaCl2. To block noradrenergic neurotransmission, the Krebs' solution also contained guanethidine (3.4 µM; Broadley, 1996
). Each segment was gently flushed with the Krebs' solution and
then divided in two halves of 20-mm length. A silk thread was tied
around either end of each preparation, thus occluding the lumen. (See
Börjesson et al., 1997
, for the rationale for the use of
"closed" instead of the conventional, "open" colon segments.)
Experimental Protocol
Effect of K+ on Preparations at Basal Tone. K+ was administered without prior precontraction of the tissues.
Analysis of K+-Induced Relaxation on Preparations
Contracted with Carbachol.
K+ was added either
noncumulatively or cumulatively to the preparations. The
pharmacological analyses of the responses to cumulative administration
of K+ was conducted according to the following. After
obtaining a control response to carbachol and K+ followed
by washouts, the following agents were incubated and, after
equilibration, carbachol followed by K+ (as above) was
again added: the nerve-blocking agent TTX (Broadley, 1996
); the
nicotinic ganglionic receptor blocker hexamethonium (Broadley, 1996
);
the inhibitor of Na+,K+-ATPase, ouabain
(Thomas, 1972
); first messenger inhibitors [ 1) apamin, a blocker of a
class of low-conductance Ca2+-dependent K+
channels in smooth muscle (Castle et al., 1989
) that is assumed to
function as a selective blocker of ATP-induced effects (Maas et al.,
1980
); 2) reactive blue 2, a putative P2y purinoceptor antagonist (see Dalziel and Westfall, 1994
, for references); 3) NG-nitro-L-arginine (L-NNA), an
inhibitor of NOS (Tøttrup et al., 1991
) or its biologically inactive
D-enantiomer
NG-nitro-D-arginine (D-NNA;
Tøttrup et al., 1991
); 4) the combination of reactive blue 2 and
L-NNA; and 5) the combination of reactive blue 2, L-NNA, and vasoactive
intestinal peptide (VIP)10-28, a VIP-receptor antagonist
(Grider and Rivier, 1990
)]; and second messenger inhibitors [ 1)
methylene blue, a proposed inhibitor of soluble guanylyl cyclase (see
Ward et al., 1992
, for references); 2)
1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one
(ODQ), a specific inhibitor of soluble guanylyl cyclase (Garthwaite et
al., 1995
); and 3)
N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), an inhibitor of cAMP-dependent protein kinase (Chijiwa et al.,
1990
)].
Effect of VIP or Sodium Nitroprusside (SNP) and of Putative Inhibitors of These Compounds on Carbachol-Precontracted Preparations and Effect of K+ and Papaverine on Tone Induced by Lidocaine. For details, see Results.
Evaluation of Results. In preliminary experiments, it was found that there were neither qualitative nor quantitative differences between the two segments of the distal colon of each animal investigated with regard to contractile activity, being either spontaneous or resulting from the administration of drugs to the tissue. The segments of each rat were subjected to different treatments. The n value signifies the number of animals investigated. Data are presented as mean ± S.E. Relaxations are expressed as percent reduction from the tone prevailing immediately before each administration of K+, VIP, or SNP. Only the nadir of relaxations monitored immediately after the addition of any of these compounds was evaluated quantitatively, except for the series in which K+ was added noncumulatively, on carbachol-induced tone; in these experiments, the complete response to added K+ was evaluated.
Nonparametric statistical analyses were made. Wilcoxon's signed rank test was used for paired data, and the Kruskal-Wallis one-way ANOVA was used for group analyses; when relevant, Spearman's rank correlation coefficient test was used (Siegel and Castellan, 1988Drugs. Apamin, L-NNA, carbamylcholine chloride (carbachol), guanethidine monosulfate, hexamethonium chloride, methylene blue, ouabain, SNP, TTX, VIP, and VIP10-28 were obtained from Sigma Chemical Co. (St. Louis, MO). D-NNA was obtained from Serva Feinbiochemica GmbH (Heidelberg, Germany). Reactive blue 2 was obtained from Research Biochemicals Inc. (Natick, MA). Pentobarbital sodium (pentobarbitalnatrium) and papaverine sulfate were purchased from Apoteksbolaget (Umeå, Sweden). ODQ was purchased from Tocris Cookson Ltd. (Bristol, UK). H-89 was obtained from Calbiochem-Novabiochem Ltd. (Nottingham, UK). ODQ was dissolved in ethanol, and H-89 was dissolved in equal amounts of ethanol and distilled water. All other drugs were dissolved in distilled water. L-NNA and D-NNA required sonification to dissolve. The administration of a similar volume of pure solvent did not affect either the spontaneous activity of the muscle or the responses to drugs.
| |
Results |
|---|
|
|
|---|
Basal Contractile Activity.
The colonic segments investigated
exhibited a low level of spontaneous contractile activity (Fig.
1), as previously described (Börjesson et al., 1997
).
|
Effect of K+ on Preparations at Basal Tone. K+ (20.8 and 50.8 mM) was administered to segments without previous precontraction (n = 3). The first concentration induced a persistent increase in tone of 7.0 ± 1.4 mN in all segments; a relaxation of ~30-s duration preceded this response in two of three experiments. The second concentration induced a further increase in tone by an additional 24.0 ± 7.2 mN; also, immediately before this effect, there was a short-lasting (<30-s) relaxation observed in one of the three segments investigated. Thus, the results obtained could indicate that K+ may elicit inhibition of the tissue also at low tone. The magnitude of this effect, however, might be underestimated, partly due to a dominant excitatory response to K+ at low tone.
General Characteristics of Effect of K+ on Precontracted Preparations
Noncumulative Administration of K+.
The
concentration-effect relationship for K+ (at 10.8, 15.8, 20.8, 25.8, or 45.8 mM, administered as a single injection to the bath)
was investigated on segments precontracted with carbachol (1 µM;
n = 6; see below for description of the effect of
carbachol). Thus, the addition to the chamber of K+ was
made 5 min after the administration of carbachol; K+ was
then allowed to remain in the bath for 10 min before washouts (five
complete changes of the Krebs' solution at 5-min intervals) were
performed. Thereafter, carbachol, followed by K+ (at the
next higher concentration), was administered. The addition of
K+ elicited an immediate relaxation. The latency of this
response, defined as the duration from the addition of K+
to half the nadir of this response, was estimated to be <1 s. The
relaxation was followed by a contraction, reaching a peak that was not
sustained but waned within 3 min before stabilizing at a steady-state
level of tone. This "new" plateau was either the same or lower than
that caused by carbachol (Fig. 2). In
fact, at an approximate concentration of K+ of
25 mM,
such a stable level of tone appeared as a second K+-induced
relaxation. This was even more evident when K+ was added
cumulatively (see below). Both the immediate response and the peak
contraction were found to be maximal at 20.8 mM.
|
Cumulative Administration of K+.
The effect of
carbachol in the current preparation has been previously investigated
(Börjesson et al., 1997
). Thus, a concentration of 1 µM was
shown to induce a response of ~55 mN, being ~70% of the maximal
effect of this compound. The response consisted of a peak contraction
that during a 5-min observation period leveled off to a fairly stable
plateau. In the following, a concentration of carbachol of 1 µM is
used throughout the study. The peak contraction to this compound was
47.4 ± 9.2 mN (first challenge) versus 57.5 ± 4.1 mN
(second challenge; P < .05), which during the
5-min observation period (before the addition of K+, see
below) leveled off to a plateau, being 37.4 ± 9.5 mN (79% of
peak value; first challenge) versus 40.8 ± 9.3 mN (71% of peak value; second challenge; P < .05).
|
Effect of K+ on Precontracted Preparations in Presence
of TTX.
TTX (1 µM; n = 13) induced an
increase in the phasic activity of the colonic muscle, suggesting a
prevailing, neurogenic inhibition (cf. Wood, 1994
; Börjesson et
al., 1997
). After an equilibration period of 20 min, basal tone
immediately before the second addition of carbachol was 115.5 ± 12.8% of the corresponding value before the first administration of
carbachol (P > .05). Carbachol-induced tone after
TTX was 129.6 ± 7.2% of the effect obtained in the absence of
this compound (P < .05). The immediate relaxation
in response to K+ was almost abolished by TTX; in fact, in
the presence of TTX, the immediate response seen after 20.8 mM
K+ was replaced by a small contraction (~3 mN; same
latency as the immediate relaxation, see above). Conversely, the slow
"secondary" relaxation in response to K+ as noted in
the absence of TTX was seemingly unchanged by this compound. Thus,
after the contractile effect, there was a slow relaxation (latency,
~1 min), with a nadir of 61.3 ± 5.2% of the tone recorded
immediately before K+ administration (Figs. 3B and 4, A and B).
Effect of K+ on Precontracted Preparations in Presence
of Hexamethonium.
Hexamethonium (1 mM; n = 6)
induced a marked increase in the phasic activity of the colonic
segments, as also reported previously (Börjesson et al., 1997
).
This compound did not significantly affect either basal tone, tone
induced by carbachol, or relaxations induced by K+ (Fig.
4, A and B).
|
Effect of Ouabain on Relaxations to K+ on Precontracted
Preparations.
After obtaining a control response to carbachol and
K+ followed by washouts, the segments were thereafter
incubated with ouabain (0.01, 0.1, 1, 10, or 100 µM) for 20 min,
followed by another challenge with carbachol and K+
(n = 6). After washouts, this experimental cycle
was then repeated with ouabain at the next higher concentration. This
compound caused a progressive, concentration-dependent increase in
basal tone of 255% of the initially recorded level at 100 µM; the
level of tone reached with the subsequent addition of carbachol was not influenced by the presence of ouabain. This agent inhibited the relaxations induced by K+ (n = 6) in a
concentration-dependent fashion (Fig. 5),
as verified with the Spearman rank correlation coefficient test
(
=
0.398 at a K+ concentration of 20.8 mM,
P = .013;
=
0.607 at a K+
concentration of 50.8 mM, P = .0002).
|
Effect of Inhibitors of First- or Second Messenger Mechanisms on Relaxations to K+ on Precontracted Preparations
First Messenger Inhibitors.
Apamin (0.5 µM;
n = 6) elicited an increase in phasic activity (cf.
Börjesson et al., 1997
) but did not significantly influence basal
tone or tone induced by carbachol. K+ induced relaxations
were significantly reduced by apamin (Fig. 4, A and B), possibly
indicating an involvement of ATP in the response.
Second Messenger Inhibitors. Methylene blue (10 µM; n = 6) did not change the phasic activity of the tissue. Basal tone was lowered by ~35% (P < .05), but tone induced by carbachol was unchanged. The relaxations in response to K+ were unaffected by methylene blue (Table 1).
|
Effect of VIP or SNP and of Putative Inhibitors of These Compounds on Carbachol-Precontracted Preparations. A single concentration of VIP (0.1 µM; n = 17) or the NO donor SNP (100 µM; n = 16; cf. Feelish and Noack, 1987) was administered. In a few experiments, after washouts, the tissues were left undisturbed for 30 min, whereupon carbachol, followed by VIP or SNP, was again added to the chambers to investigate the reproducibility of these latter compounds. VIP induced a slow relaxation to 80.9 ± 2.3% of tone recorded before the administration of this compound. This effect was seemingly reproducible (n = 3). The response to SNP mimicked the effect to VIP and relaxed the tissue to ~65% of tone recorded immediately before SNP administration; this effect was reproducible (n = 6).
In an additional series of experiments, after washouts, the preparations that had been challenged with VIP were incubated for 30 min with one of the following compounds: VIP10-28 (8 µM; n = 5), H-89 (1 µM; n = 7), or ODQ (10 µM; n = 6). These tissues were then rechallenged with carbachol followed by VIP, as above. (Because of the cost of the compound, any further analyses using VIP10-28 were not undertaken in the current study.) Conversely, the preparations that had been challenged with SNP were incubated for 30 min with either of the following compounds: methylene blue (10 µM; n = 8), ODQ, (10 µM; n = 6), or H-89 (10 µM; n = 4). The preparations were then rechallenged with carbachol followed by SNP, as above. VIP10-28 affected neither basal tone, phasic activity, nor tone induced by carbachol. The effect to VIP was reduced to 23.9 ± 11.5% of the control response. H-89 or ODQ significantly reduced the relaxation in response to VIP (Table 1). The relaxation in response to SNP was increased after methylene blue pretreatment, whereas ODQ abolished relaxations in response to SNP. Conversely, H-89 (at a concentration 10 times greater than that used elsewhere throughout the study) did not affect relaxations induced by SNP (Table 1); therefore, the results obtained strongly indicate that methylene blue is an unreliable tool to investigate the cGMP pathway. In all experiments evaluating the effect of inhibitors of first or second messengers (above), papaverine (cf. Huddart and Saad, 1980Effect of K+ and Papaverine on Tone Induced by
Lidocaine.
The local anesthetic lidocaine serves not only as a
nerve-blocking agent but also as a spasmogen (cf. Börjesson et
al., 1997
). This agent was administered on basal tone, resulting in a
stable increase in tone, that was 39.2 ± 7.4 mN after 15 min of
equilibration. Then, K+ (20.8 and 50.8 mM, as above;
n = 6) was administered. In these experiments,
K+ caused no relaxation, but qualitatively and
quantitatively contractions were seemingly not different from those
observed on carbachol-induced tone. The addition of papaverine
(n = 6) relaxed the segments to or slightly below
basal tone.
| |
Discussion |
|---|
|
|
|---|
Neurogenic Relaxation in Response to K+.
In the
current study, we extended previous observations concerning the
inhibitory effect of K+ on various parts of gut muscle (see
Tøttrup et al., 1993
, for references). Thus, in the longitudinal
muscle layer of rat distal colon, the addition of K+
elicited nonadrenergic relaxations of the tissue, the initial component
of which was almost abolished by TTX or entirely by lidocaine (see
below). By using two concentrations of K+ (20.8 and 50.8 mM), we pursued the pharmacological analysis of such a neurogenic response.
Ouabain.
Relaxation of smooth muscle may be induced by an
augmentation of the extracellular K+ as a direct effect
(Thomas, 1972
; Anderson, 1976
); the neurogenic component of the
response to K+ was maximally antagonized by ouabain (when
used instead of TTX) by ~40% of control. The net effects of ouabain
on the muscle are, however, complex because this compound may via
several mechanisms interfere with functional properties of the
motoneurons and/or muscle excitability and thereby affect the resulting
effect to K+ administration (Thomas, 1972
; Sandoval, 1980
;
Adam-Vizi, 1992
; Broadley, 1996
).
Hexamethonium. The relaxation in response to K+ was unchanged by the nicotinic receptor antagonist hexamethonium, suggesting it is due to the activation of postganglionic motoneurons.
Purinergic Neurotransmission.
The evidence for the involvement
of ATP in NANC inhibitory neurotransmission in the gastrointestinal
tract and, in particular, rat colon have been previously summarized by
Börjesson et al. (1997)
. When using either of the two compounds
apamin or reactive blue 2, we found that the relaxations induced by the
two different concentrations of K+ were antagonized by
~75 and ~45%, respectively. Therefore, we propose a considerable
purinergic component of this response.
Nitrergic Neurotransmission.
The relaxation in response to
K+ was inhibited by ~60% by L-NNA. NO is considered to
mediate smooth muscle relaxation by increasing cGMP, which in turn
causes the activation of cGMP-dependent protein kinase (Hobbs and
Ignarro, 1996
). In the current study, although the cAMP blocker H-89
did not affect the response to the NO donor SNP, this effect was
abolished by the cGMP inhibitor ODQ. This finding strongly indicates
that SNP relaxes gut muscle singularly via cGMP activation (cf. Murthy
and Makhlouf, 1995
). Moreover, ODQ diminished the inhibitory effect of
K+ by ~60%, in concert with the view that the relaxation
in response to K+ is greatly dependent on NO.
VIP-ergic Neurotransmission.
There are previous
immunohistochemical (Browning and Lees, 1994
) and pharmacological
(Suthamnatpong et al., 1993
) data that may support a role for VIP in
the K+-induced relaxation. The intracellular mechanisms via
which VIP induces gut muscle relaxation is complex; both the cAMP
(Bitar and Makhlouf, 1982
; Jin et al., 1993
) and cGMP (Jin et al.,
1993
; Murthy and Makhlouf, 1995
) pathways may be involved. The view that neurally released VIP in turn causes the release of NO (see Jin et
al., 1993
, for older references; Dick and Lefebvre, 1998
) is, however,
controversial (Sanders et al., 1992
). In the current study, VIP was
found to relax the precontracted tissue, a response antagonized by the
VIP receptor antagonist VIP10-28 by 75%. Such relaxations
could be reduced by H-89 (by 50%) or ODQ (by 60%). Furthermore, only
the relaxation induced by 20.8 mM K+ (but not 50.8 mM) was
significantly reduced by H-89 (by 40%), an observation that could
suggest VIP has only a minor role in this effect.
Comparisons with Previous Findings.
The relaxation in response
to 20.8 and 50.8 mM K+ on the longitudinal muscle of rat
distal colon, as obtained in the current study, differs from that
elicited by 10 mM K+ on longitudinal muscle of canine
duodenum (Toda et al., 1992
) in the following respects.
| |
Acknowledgments |
|---|
We are very grateful to Dr. Holger Wigström for his invaluable comments. Lena Hultman is acknowledged for expert technical assistance.
| |
Footnotes |
|---|
Accepted for publication July 22, 1999.
Received for publication May 3, 1999.
1 This work was supported by The Göteborg Medical Society and the Swedish Medical Research Council (Grants 11611 and 03117).
Send reprint requests to: Dr. Dick S. Delbro, Department of Surgery, Institute of Surgical Sciences, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden. E-mail: dick.delbro{at}medfak.gu.se
| |
Abbreviations |
|---|
TTX, tetrodotoxin; NOS, nitric oxide synthase; VIP, vasoactive intestinal peptide; L-NNA, NG-nitro-L-arginine; D-NNA, NG-nitro-D-arginine; ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one; H-89, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide; SNP, sodium nitroprusside.
| |
References |
|---|
|
|
|---|
-conotoxins GVIA, MVIIA, MVIIC and SVIB.
Br J Pharmacol
118:
797-803[Medline].
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||